Trial Profile
A Randomized, Double-Blinded, Placebo-Controlled Protocol of Oral Cyclosporine in Patients With Advanced Stage Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 03 Oct 2017 Status changed from active, no longer recruiting to completed.
- 04 Jan 2016 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 04 Jan 2016 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2016, according to ClinicalTrials.gov record.